Atherosclerosis, the build-up of fatty plaque in arteries, usually affects people older than 50, but a "meaningful" ...
Coverage of a new PCSK9 trial makes bold claims about prevention and risk reduction. But how well do they hold up to scrutiny ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results